Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Y Graham

Showing results (531-540 of 635) with videos related to

Pageof 64
Sort By:
Alimentary Pharmacology & Therapeutics|June 1, 1997
Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pyloriT Breuer, J G Kim, I E Gurer, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pyloriD H Kwon, F A El-Zaatari, M Kato, et al.
Gastrointestinal Endoscopy|September 29, 2001
Duodenal erosions after eradication of Helicobacter pylori infectionA Shiotani, S Nishioka, M Iguchi, et al.
The American Journal of Gastroenterology|March 31, 2001
Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patientsEl-Zimaity HMT, O Gutierrez, J G Kim, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1996
Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazoleC Y Hachem, J E Clarridge, R Reddy, et al.
Digestive Diseases and Sciences|May 20, 1998
REP-PCR fragments as biomarkers for differentiating gastroduodenal disease-specific Helicobacter pylori strainsD H Kwon, F A El-Zaatari, J S Woo, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2002
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus ReportP Malfertheiner, F Mégraud, C O'Morain, et al.
Annals of Internal Medicine|August 1, 1991
Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trialN M Agrawal, S Roth, D Y Graham, et al.
Current Microbiology|July 15, 1998
The effect of galE gene inactivation on lipopolysaccharide profile of Helicobacter pyloriD H Kwon, J S Woo, C L Perng, et al.
Alimentary Pharmacology & Therapeutics|November 14, 1997
Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in KoreaT Breuer, J G Kim, H M el-Zimaity, et al.
Pageof 64

Showing results (531-540 of 635) with videos related to

Sort By:
Pageof 64
Alimentary Pharmacology & Therapeutics|June 1, 1997
Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pyloriT Breuer, J G Kim, I E Gurer, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pyloriD H Kwon, F A El-Zaatari, M Kato, et al.
Gastrointestinal Endoscopy|September 29, 2001
Duodenal erosions after eradication of Helicobacter pylori infectionA Shiotani, S Nishioka, M Iguchi, et al.
The American Journal of Gastroenterology|March 31, 2001
Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patientsEl-Zimaity HMT, O Gutierrez, J G Kim, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1996
Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazoleC Y Hachem, J E Clarridge, R Reddy, et al.
Digestive Diseases and Sciences|May 20, 1998
REP-PCR fragments as biomarkers for differentiating gastroduodenal disease-specific Helicobacter pylori strainsD H Kwon, F A El-Zaatari, J S Woo, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2002
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus ReportP Malfertheiner, F Mégraud, C O'Morain, et al.
Annals of Internal Medicine|August 1, 1991
Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trialN M Agrawal, S Roth, D Y Graham, et al.
Current Microbiology|July 15, 1998
The effect of galE gene inactivation on lipopolysaccharide profile of Helicobacter pyloriD H Kwon, J S Woo, C L Perng, et al.
Alimentary Pharmacology & Therapeutics|November 14, 1997
Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in KoreaT Breuer, J G Kim, H M el-Zimaity, et al.
Pageof 64